Newzchain
News·Health care

WHO Launches Global Strategic Plan to Fight Rising Dengue and Other Aedes-Borne Arboviral Diseases

Shailaja Pathak
Shailaja Pathak·Oct 4, 2024·2 min read
World Health Organization launches Global Strategic Preparedness, Readiness and Response Plan for dengue and Aedes-borne dise

On Thursday, the World Health Organization (WHO) launched the Global Strategic Preparedness, Readiness, and Response Plan (SPRP) to address dengue and other diseases spread by Aedes mosquitoes. 

The plan aims to reduce illness, suffering, and deaths from dengue, Zika, chikungunya, and similar viruses through a coordinated global response.

Currently, about four billion people are at risk of contracting arboviruses globally, and this number could rise to five billion by 2050. Dengue cases have spiked across all six WHO regions, nearly doubling each year since 2021. And by the end of August this year, over 12.3 million cases were reported—almost double the 6.5 million cases recorded for all of 2023.

“The rapid spread of dengue and other arboviral diseases in recent years is an alarming trend that demands a coordinated response across sectors and across borders,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.

The plan details key actions to control disease spread and provides recommendations for affected countries in areas like surveillance, lab work, vector control, community engagement, clinical management, and research. It takes a whole-of-society and regional approach.

Newsletter

The corridor, every morning.

Funding rounds and cross-border capital moves, one email, five minutes.

The SPRP comprises five key components essential for a successful outbreak response:  

The plan will be implemented over one year until September 2025 and requires $55 million to support health preparedness, readiness, and response efforts.


Edited by Harshajit Sarmah

ALSO READ:

WHO-Approved Qdenga Vaccine Reduce Dengue Cases by Over 50%
Developed by Japan’s Takeda Pharmaceutical Industries, the Qdenga vaccine, also known as TAK-003, is a live-attenuated vaccine. Meaning, it contains weakened forms of the four types of the DENV virus.

More in News